CTU Phase i first in human study of a first in class CD79bxCD20xCD3 trispecific antibody JNJ-80948543 in B-cell lymphoid malignancies

  • Di Ciaccio, Pietro (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymJNJ-80954385LYM1001
StatusActive
Effective start/end date6/09/228/08/27